Journals / Türk Oftalmoloji Dergisi / 2012 / Cilt: 42 - Sayı: 3

Application of amniotic membrane in ocular surface diseases: clinical features and treatment outcomes

Oküler yüzey rekonstrüksiyonunda amniyon zarı uygulamaları: klinik özellikler ve tedavi sonuçları

Pages
177–182
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is a safe and effective procedure in ocular surface disease. (Turk J Ophthalmol 2012; 42: 177-82)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the effectiveness of amniotic membrane transplantation in cases with corneal thinning, desmatocele and refractive corneal ulcer.
📊
Key Findings & Data:Material and Method: Fifty-four eyes of 54 patients who were applied amniotic membrane transplantation for various ocular surface disease between January 2004 and February 2009 in Çukurova University Ophthalmology Department were included in the study.
💡
Conclusion & Impact:It is a safe and effective procedure in ocular surface disease. (Turk J Ophthalmol 2012; 42: 177-82)
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate the effectiveness of amniotic membrane transplantation in cases with corneal thinning, desmatocele and refractive corneal ulcer. Material and Method: Fifty-four eyes of 54 patients who were applied amniotic membrane transplantation for various ocular surface disease between January 2004 and February 2009 in Çukurova University Ophthalmology Department were included in the study. A complete ophthalmologic examination was performed. Corneal culture and corneal cytology samples were collected from the patients with the diagnosis of corneal ulcers. The patients were informed about the surgical procedure and the possible complications and informed consent was obtained. The amniotic membranes that were prepared under optimal conditions and protected in frozen forms were used in the operations. Follow-up examinations were done at postoperative 1st day, 1st week, 1st month, 3rd month, 6th month and then once in a year.Results: Of 54 patients, 26 (48.1%) were men and 28 (51.8%) were women. The mean age of patients was 52.53±19.75 (2-87) years. The cases were separated into 2 groups according to the etiology: group 1 - eyes with corneal ulcer (n:26) and group 2 - eyes with corneal stromal thinning, persistent epithelial defects and desmatocel (n:28). The transplantations were performed using cover technique in 17 eyes (31.4%), graft technique in 37 eyes (68.5%) and graft technique with corneal patch in 2 eyes (3.7%). Partial penetrating keratoplasty was required in 38 of 54 eyes (70.3%). One eye was enucleated. Discussion: The amniotic membrane transplantation has advantages like: it can be prepared easily and is cost-effective. It is a safe and effective procedure in ocular surface disease. (Turk J Ophthalmol 2012; 42: 177-82)

Özet

Amaç: Tedaviye dirençli korneal ülser, korneal incelme ve desmatosel olgularında amniyon zar transplantasyonunun etkinliğini araştırmak. Gereç ve Yöntem: Ocak 2004-Şubat 2009 tarihleri arasında Çukurova Üniversitesi Tıp Fakültesi Göz Hastalıkları Anabilim Dalı’na başvuran ve farklı oküler yüzey hastalıkları nedeniyle amniyon zar transplantasyonu uygulanan 54 hastanın 54 gözü çalışmaya alındı. Hastalara tam bir oftalmolojik muayene yapıldı. Kornea ülseri tanısı konulan hastalardan sitoloji ve kültür örnekleri alındı. Hastalara yapılacak cerrahi işlem ve olabilecek komplikasyonlar hakkında bilgi verilerek aydınlatılmış onam formu alındı. Ameliyatlarda uygun şartlarda hazırlanıp dondurulmuş şekilde saklanan amniyon zarları kullanıldı. Hastalar ameliyat sonrası 1. gün, 1. hafta, 1. ay, 3. ay, 6. ay ve sonrasında yıllık rutin kontrole çağrıldı.Sonuçlar: Olguların 26’sı (%48,1) erkek, 28’i (%51,8) kadın idi. Ortalama yaş 52,53±19,75 idi (2-87). Olgular etiyolojilerine göre 2 gruba ayrıldı. Olguların 26’sında kornea ülseri (grup 1), 28’inde kornea stromasında incelme ve persistan epitel defekti ile desmatosel (grup 2) mevcuttu. Onyedi olguya (%31,4) örtü tekniği, 37 olguya (%68,5) greft tekniği, 2 olguya (%3,7) greft tekniği ile birlikte korneal yama uygulandı. Çalışmaya alınan 54 hastanın 38’ine (%70,3) parsiyel penetran keratoplasti planlandı. Bir hastaya enükleasyon uygulandı. Tartışma: Amniyon zarının kolay hazırlanması ve maliyetinin çok yüksek olmaması gibi avantajları mevcuttur. Amniyon zar transplantasyonu oküler yüzey hastalıklarında güvenilir ve etkin bir yöntemdir. (Turk J Ophthalmol 2012; 42: 177-82)

🔖

Cite This Article

ERDEM, E., CİNDARİK, D., YAĞMUR, M., ŞEKEROĞLU, H. T. (2022). Application of amniotic membrane in ocular surface diseases: clinical features and treatment outcomes. Türk Oftalmoloji Dergisi, Cilt: 42 - Sayı: 3, 177–182. https://ajindex.com/articles/638249

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Saw VP, Minassian D, Dart JK, et al. Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from UK user group Br J Ophthalmol. 2007;91:1042-7
  2. Kenyon KR, Roberts CW. Noninfected corneal ulceration. Int Ophtalmol Clin. 1984;24:179-97
  3. Donshik P. Therapeutic contact lenses. Ophtalmol Clin North Am. 1989;2:229-311
  4. Feder R, Krachmer J. Conjunctival resection for treatment of the rheumatoid corneal ulceration. Ophtalmology. 1984;91:111-5
  5. Bessant DA, Dart JK. Lamellar keratoplasty in the management of inflammatory corneal ulceration. Eye (Lond). 1994;8:22-8
  6. Donzis PB, Mondino BJ. Management of noninfectious corneal ulcers. Surv Ophthalmol. 1987;32:94-110
  7. Portnoy SL, Insler MS, Kaufman HE.Surgical management of corneal ulceration and perforation. Surv Ophthalmol. 1989;34:47-58
  8. Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic membrane transplantation: A review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol. 2007;55:251-60
  9. Doğru M, Tsubota K. Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency. Am J Ophthalmol. 2005;40:305-6
  10. Yaycıoğlu RA, Akova YA. Amniyon Membran Transplantasyonunun Oftalmolojide Yeri. Türkiye Klinikleri J Ophthlmol. 2003;12:227-36
  11. Grueterich M, Espana EM, Tseng SC.Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv Ophthalmol. 2003;48:631-46
  12. Davis JW. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital Johns Hopkins Med. J 1910;15:307. 13. de Rotth A. Plastic repair of conjunctival defects with fetal membrane. Arch Ohthalmol. 1940;23:522-5
  13. Sorsby A, Symons HM. Amniotic membrane grafts in coustic burns of the eye. Br J Ophthalmol. 1946;30:337-45
  14. Sorsby A, Hythorne J, Reed H. Futher experience with amniotic membrane grafts in coustic burns of the eye. Br J Ophthalmol. 1947;31:409-18
  15. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severly damaged rabbit comeas. Cornea. 1995;14:473-84
  16. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-12
  17. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and l